Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
23.04
+2.03 (9.66%)
At close: Feb 6, 2026, 4:00 PM EST
23.14
+0.10 (0.43%)
After-hours: Feb 6, 2026, 7:44 PM EST
Kodiak Sciences Employees
Kodiak Sciences had 123 employees as of September 30, 2025. The number of employees increased by 15 or 13.89% compared to the same quarter last year.
Employees
123
Change
15
Growth
13.89%
Revenue / Employee
n/a
Profits / Employee
-$1,766,959
Market Cap
1.43B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 123 | 15 | 13.89% |
| Jun 30, 2025 | 121 | 10 | 9.01% |
| Mar 31, 2025 | 113 | 6 | 5.61% |
| Dec 31, 2024 | 109 | -2 | -1.80% |
| Sep 30, 2024 | 108 | -8 | -6.90% |
| Jun 30, 2024 | 111 | -7 | -5.93% |
| Mar 31, 2024 | 107 | -8 | -6.96% |
| Dec 31, 2023 | 111 | -1 | -0.89% |
| Sep 30, 2023 | 116 | 11 | 10.48% |
| Jun 30, 2023 | 118 | 17 | 16.83% |
| Mar 31, 2023 | 115 | 14 | 13.86% |
| Dec 31, 2022 | 112 | 19 | 20.43% |
| Sep 30, 2022 | 105 | 20 | 23.53% |
| Jun 30, 2022 | 101 | 25 | 32.89% |
| Mar 31, 2022 | 101 | 24 | 31.17% |
| Dec 31, 2021 | 93 | 21 | 29.17% |
| Sep 30, 2021 | 85 | 23 | 37.10% |
| Jun 30, 2021 | 76 | 28 | 58.33% |
| Mar 31, 2021 | 77 | 36 | 87.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,500 |
| Novavax | 952 |
| Intellia Therapeutics | 403 |
| Biohaven | 256 |
| Relay Therapeutics | 188 |
| Precigen | 143 |
| AnaptysBio | 136 |
| AtaiBeckley | 54 |
KOD News
- 4 days ago - Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026 - PRNewsWire
- 17 days ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 26 days ago - Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 7 weeks ago - Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 7 weeks ago - Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock - PRNewsWire
- 7 weeks ago - Kodiak Sciences Announces Proposed Public Offering of Common Stock - PRNewsWire
- 3 months ago - Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results - PRNewsWire